Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 17, Issue 8, Pages 321-327Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2006.08.005
Keywords
-
Categories
Funding
- NCI NIH HHS [CA 52599] Funding Source: Medline
- NHLBI NIH HHS [HL 56989] Funding Source: Medline
- NIGMS NIH HHS [GM 069338] Funding Source: Medline
Ask authors/readers for more resources
Inflammation is a beneficial host response to external challenge or cellular injury that leads to the activation of a complex array of inflammatory mediators, finalizing the restoration of tissue structure and function. Although a beneficial response, prolonged inflammation can be detrimental to the host, contributing to the pathogenesis of many disease states. Considerable attention has been focused on the ability of several members of the nuclear receptor superfamily to inhibit transcriptional activation by signal-dependent transcription factors that include nuclear factor kappa B and activator protein 1, thereby, attenuating inflammatory responses to both acute and chronic challenge. An important general mechanism responsible for this activity is referred to as transrepression, in which nuclear receptors interfere with signal-dependent activation of inflammatory response genes through protein-protein interactions with coregulatory proteins and promoter-bound transcription factors, rather than direct, sequence-specific interactions with DNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available